{"text": ["Pfizer", "(PFE)", "Outpaces", "Stock", "Market", "Gains:", "What", "You", "Should", "Know"], "created_at": "2019-12-23 22:45:10"}
{"text": ["GlaxoSmithKline's", "Long-Acting", "HIV", "Regimen", "Gets", "CRL", "From", "FDA"], "created_at": "2019-12-23 14:40:02"}
{"text": ["Bristol-Myers'", "Revlimid", "Combo", "Gets", "EU", "Nod", "for", "New", "Indication"], "created_at": "2019-12-23 14:20:02"}
{"text": ["Theravance", "Biopharma", "and", "Pfizer", "Inc.", "Enter", "Global", "License", "Agreement", "for", "Skin-Targeted,", "Locally-Acting", "Pan-Janus", "Kinase", "(JAK)", "Inhibitor", "Program"], "created_at": "2019-12-23 13:15:00"}
